JENSEN JESSICA D. 4
4 · POINT Biopharma Global Inc. · Filed Jul 8, 2021
Insider Transaction Report
Form 4
JENSEN JESSICA D.
EVP Clinical Development
Transactions
- Award
Stock Option (Right to Buy)
2021-07-06+461,250→ 461,250 totalExercise: $8.47Exp: 2027-07-06→ Common Stock (461,250 underlying)
Footnotes (1)
- [F1]The option vests 25% on July 6, 2022 with the remaining 75% vesting in three equal annual installments thereafter.